Skip to main content
Equibles

DAFNA Capital Management LLC

Position in PRQR — ProQR Therapeutics N.V.

CIK 1389933 LOS ANGELES, CA
Back to PRQR Full portfolio

Position in PRQR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,846,471
+$307,023 QoQ
Shares Held
1,530,361
-2.4% QoQ
Ownership
1.08%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
#11
of 69 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PRQR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DAFNA Capital Management LLC holds $345,637,467 across 65 Biotechnology names. PRQR ranks #22 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 562,630 $105,369,346
2 NKTR
Nektar Therapeutics
 318,380 $22,226,107
3 DNLI
Denali Therapeutics Inc.
 739,014 $19,007,440
4 IDYA
IDEAYA Biosciences, Inc.
 497,240 $18,532,134
5 XENE
Xenon Pharmaceuticals Inc.
 250,772 $15,136,597
6 CYTK
Cytokinetics Inc
 171,998 $14,652,509
7 RCUS
Arcus Biosciences, Inc.
 441,829 $13,621,588
8 ASND
Ascendis Pharma A/S
 48,469 $12,927,651

All Filings in PRQR

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,846,471 1,530,361
2026-03-31 $2,539,448 1,567,561
2025-12-31 $3,166,473 1,567,561
2025-09-30 $3,338,904 1,567,561
2025-06-30 $3,197,824 1,567,561
2025-03-31 $2,084,856 1,567,561
2024-12-31 $4,154,036 1,567,561
2024-09-30 $1,648,159 905,582
2024-06-30 $1,503,266 905,582
2024-03-31 $2,073,782 905,582
2023-12-31 $1,862,352 940,582
2023-09-30 $1,222,756 940,582
2023-06-30 $1,523,742 940,582
2023-03-31 $2,003,439 940,582
2022-09-30 $483,140 649,383
2021-12-31 $684,662 85,476
2021-09-30 $2,480,725 296,383
2021-06-30 $6,954,871 1,031,880
2021-03-31 $7,271,000 1,100,000
2020-12-31 $5,197,080 1,237,400
2020-09-30 $5,927,146 1,237,400
2020-06-30 $7,523,392 1,237,400
2020-03-31 $6,793,326 1,237,400